Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Aug-23 4:47 PM View:  | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Aug-23 | Sale | 509 | $34.88 | $17,751.40 | (< 1%) 52.95K to 52.44K | |
| 07-Jun-23 9:36 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 1,857 | $37.87 | $70,315.30 | (4%) 43.21K to 41.36K | |
| 07-Jun-23 9:36 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 1,779 | $38.99 | $69,365.00 | (4%) 44.99K to 43.21K | |
| 05-Aug-22 4:06 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Aug-22 | Market Sale | 476 | $55.70 | $26,513.20 | (1%) 45.47K to 44.99K | (10%) |
| 08-Jun-22 7:48 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-22 | Grant | 9,900 | -- | -- | 28% 35.16K to 45.06K | |
| 08-Jun-22 7:48 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-22 | Option Exercise | 6,250 | $34.38 | $214,844.00 | 13% 46.46K to 52.71K | |
| 08-Jun-22 7:48 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-22 | Option Sale | 2,099 | $61.37 | $128,824.00 | (4%) 52.71K to 50.61K | |
| 08-Jun-22 7:48 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-22 | Planned Option Sale | 4,151 | $61.39 | $254,835.00 | (8%) 50.61K to 46.46K | |
| 08-Jun-22 7:48 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-22 | Sale (Planned) | 11,296 | $61.39 | $693,476.00 | (24%) 46.46K to 35.16K | |
| 08-Nov-21 4:22 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Nov-21 | Option Exercise | 10,000 | $48.15 | $481,500.00 | 27% 36.46K to 46.46K | |
| 05-Aug-21 4:33 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Aug-21 | Grant | 5,000 | -- | -- | 16% 31.46K to 36.46K | |
| 11-Jun-21 8:37 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-21 | Grant | 7,000 | -- | -- | 29% 24.04K to 31.04K | |
| 08-Jun-21 4:20 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-21 | Market Sale | 2,276 | $61.04 | $138,920.00 | (9%) 26.31K to 24.04K | (1%) |
| 02-Apr-21 6:33 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 31-Mar-21 | Option Exercise | 13,750 | $34.38 | $472,656.00 | 40% 34.78K to 48.53K | |
| 02-Apr-21 6:33 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 31-Mar-21 | Market Option Sale (Planned) | 13,750 | $70.61 | $970,862.00 | (28%) 48.53K to 34.78K | |
| 02-Apr-21 6:33 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 31-Mar-21 | Market Sale (Planned) | 8,474 | $70.61 | $598,333.00 | (24%) 34.78K to 26.31K | |
| 17-Nov-20 5:30 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Nov-20 | Market Sale (Planned) | 5,000 | $62.00 | $310,000.00 | (13%) 39.78K to 34.78K | 4% |
| 11-Jun-20 6:36 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-20 | Grant | 14,000 | -- | -- | 55% 25.24K to 39.24K | |
| 12-Mar-20 7:18 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 11-Mar-20 | Market Purchase | 2,500 | $36.50 | $91,250.00 | 11% 22.74K to 25.24K | 62% |
| 06-Jun-19 5:08 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-19 | Grant | 5,600 | -- | -- | 34% 16.54K to 22.14K | |
| 06-Jun-19 5:08 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-19 | Market Sale | 722 | $42.91 | $30,981.00 | (4%) 17.26K to 16.54K | (38%) |